Security key
501976104
Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX)
CUSIP: 501976104
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Total 13F shares
- 22,688,863
- Total 13F value
- $136,134,153
- Share change
- -540,862
- SEC-reported price per share
- $6.00
- Number of holders
- 74
- Value change
- -$2,158,017
- Number of buys
- 27
- Number of sells
- 42
- Shares outstanding
- 56,833,213
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
74
Top holders
10
KYTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Kyverna Therapeutics, Inc. SEC filings
Kyverna Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501976104
Recent filing periods:
Ownership snapshot
Top reported holders of KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vida Ventures Advisors, LLC
Disclosed value leader
Vida Ventures Advisors, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13F
3/4/5
Lead comparable stake: 8%
Showing 1-6 of 15 holder rows.
Quick read
Vida Ventures Advisors, LLC leads the comparable SEC ownership view at 8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vida Ventures Advisors, LLC's linked filing trail.
Comparable ownership
Top 5
Vida Ventures Advisors, LLC
8%
GILEAD SCIENCES, INC.
7.3%
Bain Capital Life Sciences Invest...
5.9%
PRICE T ROWE ASSOCIATES INC /MD/
3.2%
VANGUARD GROUP INC
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vida Ventures Advisors, LLC |
13F
Company
|
8%
|
$13,888,447
4,523,924 shares
|
— | 30 Jun 2025 |
| GILEAD SCIENCES, INC. |
13F
3/4/5
Company · 10%+ Owner
|
7.3%
|
$12,667,185
4,126,119 shares
|
— | 30 Jun 2025 |
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
Company · 10%+ Owner
|
5.9%
|
$10,340,896
3,368,370 shares
|
— | 30 Jun 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
3.2%
|
$5,621,000
1,830,501 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
2.3%
|
$4,030,195
1,312,767 shares
|
— | 30 Jun 2025 |
| Insight Holdings Group, LLC |
13F
Company
|
1.7%
|
$3,036,396
989,054 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
74
Shares
22,688,863
Rows available
74
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
77
Q3 2025 holders
74
Holder diff
-3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend